Search Results

Watch Episode 170 What We’re Missing in Pain Research In GPCR drug discovery, receptors typically steal explicitly interested in GPCR signaling... but the thing about GPCRs... is you always kind of end up landing at a GPCR as a major target." Serafini highlighted that in modern pain drug development, the field has remained too focused on ion Takeaway Forget what you think you know about GPCR drug targets.

GPCRs Re-Enter the Story — Not as Theory, but as Tools GPCRs have always been powerful drug targets — yet challenging to drug. That partnership eventually produced fluorescent GPCR tools  that allow researchers to visualize GPCR are expressed Observing which cell types  respond to different therapies Understanding why similar drugs Emerging direction: Peptide–drug conjugates for precision targeting.

February 2022 Septerna emerges with $100M to spark 'second golden age' of prolific drug target GPCR with co-founder "Jan 27, 2022 07:00am Septerna wants to spark a second golden age in G-protein-coupled receptor drug Better known as GPCR, the fruitful research space has led to more than 700 approved drugs over previous with the target and analogizes the search for new drugs to oil drilling around the world." Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR. dramatically improve how scientists measure ligand-receptor interactions, visualize binding in live cells, and design GPCR empowers scientists and companies advancing receptor biology and drug discovery. a biotech company based in Spain that specializes in the development of optimal chemical tools for drug generation of conjugates, such as labeled ligands, with excellent affinity and pharmacological profiles, designed

How a Chemical Design Sparked a GPCR Imaging Breakthrough The concept was elegant: antibodies weren’t Could these tools scale to multiple GPCRs? The design didn't just work — it revealed. Interdisciplinary design isn’t optional in GPCR imaging. It’s the catalyst. strategies for parallel receptor mapping Super-resolution imaging of receptor nanodomains AI-assisted probe design  🎧 Listen to the full episode https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/chemical-probes-for-gpcr-imaging-and-internalization

For this reason, GPCRs have been a focus of drug development for decades due to their role in regulating Conventional GPCR drug discovery has largely focused on orthosteric sites, but recent breakthroughs in The process of designing and evaluating biased ligands for GPCRs is complex but essential for understanding for designing effective drug molecules. allosteric agonists and establish a strong foundation for developing biased drugs targeting GPCRs.

drug discovery. translational research models, further refining his interest in bridging molecular insights with therapeutic design could be leveraged for therapeutic innovation, he saw a gap in the drug discovery landscape. The company’s goal is to model receptor dynamics — including biased signaling — to predict drug behavior early career redirection to startup setbacks, each step has added new layers to his thinking about drug

GPCR Virtual Cafe. This time with none other than Dr. https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

Hello GPCR Trailblazers, This week, we’re spotlighting Celtarys Research, our newest partner, featured Maria Majellaro, highlighting their fluorescent ligand tools for live-cell GPCR assays.   GPCR Updates Terry’s Corner Is Coming – Get Early Access and Updates    Terry’s Corner is launching Explore Terry's Corner From Chemistry Lab to GPCR Partner – New Podcast with Celtarys Dr. GPCR Team

October 2022 Identification of A2BAR as a potential target in colorectal cancer using novel fluorescent GPCR ligands "G-protein coupled receptors (GPCRs) have been largely targeted in a wide range of diseases, but few therapies have been directed against GPCRs in the field of cancer, partly because of the lack imaging, and as possible new tools used for target validation in drug screening methodologies." Read more at the source #DrGPCR #GPCR #IndustryNews

GPCRs remain one of the most prolific and fertile therapeutic drug targets. drug discovery. Logo Contest: Unleash your creativity and submit your design by August 15, 2024. in drug discovery October 2024 | Biologics US 2024 October 2 - 4, 2024 | 9th GPCRs in Medicinal Chemistry Director GPCR Drug Discovery Biologist Post-Doctoral Scientist- Molecular Pharmacology (FDE) Join Dr.

August 2022 "GPCRs modulate a plethora of physiological processes and mediate the effects of one-third of FDA-approved drugs. Ligands eliciting biased signalling may constitute better drugs with higher efficacy and fewer adverse Here, we provide guidelines and terminology for any scientists to design and report ligand bias experiments Read more at the source #DrGPCR #GPCR #IndustryNews

signaling proteins that participate in many vital physiological functions making them a popular target for drug Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR targeting drugs: orthosteric vs allosteric sites Most of the drugs targeting GPCRs bind to the orthosteric Despite the existence of numerous drugs designed for this primary binding site, there are significant with accessory proteins, dimerization, phosphorylation, internalization, or desensitization), the same drug This variability in drug effects is due to different ligands inducing unique GPCR conformations that To understand how ligands or drugs affect GPCRs is crucial to grasp the dynamics of these conformational

His work highlights how foundational GPCR science can drive therapeutic innovation. The GPCR Angle Ben sees GPCRs as untapped goldmines for drug discovery. Ready to dive deeper into GPCR drug discovery? Want to push the boundaries of GPCR drug discovery? Start learning with our GPCR University today. _______________ Keyword Cloud: GPCR research community , GPCR drug discovery, mu-opioid receptor, positive allosteric modulators, GPCR training program, GPCR

GPCR podcast is now available! Our guest is Mark Schmeizl! Listen where you get your podcasts https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #drgpcr #gpcr #podcast

High-content screening (HCS) has become a cornerstone in GPCR and phenotypic drug discovery, enabling Overcoming them requires careful assay design and strategic use of the right fluorescent probes. In this blog, you’ll learn:  How HCS works and why it is increasingly central to GPCR-based drug discovery Assay Design and Pilot Optimization Successful HCS begins with a clearly defined biological question Conclusion High-content screening continues to reshape GPCR drug discovery, offering richer biological

factors has renewed interest in the scientific understanding and translational potential of psychedelic drugs incremental progress in basic and clinical research, and the reconsideration and relaxation of existing drug With the United States Food and Drug Administration's designation of psilocybin as a "Breakthrough Therapy Here we review the current knowledge regarding the molecular details of psychedelic drug actions and Read more at the source #DrGPCR #GPCR #IndustryNews

May 2022 "Seoul, South Korea, 28 April 2022 – GPCR therapeutics, Inc., a venture-backed clinical stage international biopharmaceutical company with an innovative approach to drug discovery based on targeting G Protein Coupled Receptors (GPCR) pairs, today announced four appointments to its Scientific Advisory GPCR just had a very successful first meeting including all the Scientific Advisory Board." Read more at the source #DrGPCR #GPCR #IndustryNews

October 2022 "While the role of G-protein-coupled receptors (GPCR) in cancer is acknowledged, their underlying Protease-activated receptors (PAR), a subgroup of GPCRs, form a family of four members (PAR1-4) centrally We propose that Pc(4-4) may serve as a powerful drug not only toward PAR-expressing tumors but also for Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR Ecosystem paid membership with extra benefits? 🔬Join the #GPCR movement today! ➡️ https://www.ecosystem.drgpcr.com/plans-pricing #gpcr #drgpcr

August 2022 "As important drug targets, G protein-coupled receptors (GPCRs) play pivotal roles in a wide Extensive efforts of structural biology have been made on the study of GPCRs. differences impeded the use of predicted structure models in the functional study and structure-based drug design of GPCRs, which required reliable high-resolution structural information." Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR podcast is now available! Our guest is Dr. Adriano Marchese! Learn about his remarkable career and research in #GPCR signaling and trafficking. Listen where you get your podcasts https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/ #drgpcr #gpcr #podcast

August 2022 "The common mechanisms by which members of the G protein-coupled receptor (GPCR) family respond However, it is becoming increasingly clear that GPCRs show great diversity in their intracellular location Here we will discuss recent studies on the diversity of location, effectors, and signaling of GPCRs, and how these could interact to generate specific spatiotemporal patterns of GPCR signaling in cells. Read more at the source #DrGPCR #GPCR #IndustryNews

Rho1 signaling is activated by G-protein-coupled receptor (GPCR) signaling at the cell surface. During Drosophila embryonic salivary gland (SG) invagination, the GPCR ligand Folded gastrulation (Fog Here, we reveal that the Smog GPCR transduces Fog signal to regulate Rho kinase accumulation and myosin Read more at the source #DrGPCR #GPCR #IndustryNews

Join us and learn how to quantify your kinetic GPCR signaling from the expert himself: Dr. https://www.ecosystem.drgpcr.com/dr-gpcr-virtual-cafe/ #gpcr #drgpcr #virtualcafe

Instead of creating another black-box assay, they designed pHSense around rare-earth europium probes. The Chemistry That Almost Didn’t Work Designing pH-sensitive rare-earth complexes was not an obvious Just a plate reader, an agonist, and an endogenous GPCR. GPCR   Dr. GPCR X Revvity Collaboration ⸻ Want more like this? 👉 Join the Dr. GPCR Premium Ecosystem for behind-the-scenes access to GPCR innovators, exclusive deep-dives, and practical

In order to expand its role in GPCRs, which antibodies tend to have more trouble binding to. How Fluorescent Ligands Transform Flow Cytometry in GPCR Analysis GPCRs are a tough target in traditional At Celtarys, we support this transition by offering optimized fluorescent ligands specifically designed for GPCR targets , including CELT-240 for hD2/D3 dopamine receptors and CELT-483 for the hσ1/σ2 sigma Illuminating the life of GPCRs.

GPCR Ecosystem with a paid membership for extra benefits. Catch up with the latest #GPCR news, our monthly Virtual Cafe, and much more! Join the #GPCR movement today! ➡️ https://bit.ly/3SUkB8D

biosensors involves the use of mini-G proteins, which are genetically engineered portions of Gα subunits designed Allosteric Modulator Discovery: From Serendipity to Structure-Based Design. Allosteric modulation of GPCRs: From structural insights to in silico drug discovery. Rational design of allosteric modulators: Challenges and successes. Biased Allosteric Modulators: New Frontiers in GPCR Drug Discovery.